Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Alexey G. Manikhas"'
Autor:
Liudmila G. Zhukova, Larisa V. Bolotina, Victoria V. Dvornichenko, Natalia V. Fadeeva, Inna P. Ganshina, Katerina S. Grechukhina, Alfiya I. Hasanova, Nikolay V. Kislov, Igor Yu. Kudryavtsev, Alexey G. Manikhas, Natalia E. Musaeva, Alexandra A. Nizhegorodtseva, Olga E. Sadikova, Dina D. Sakaeva, Anton V. Snegovoy, Daniil L. Stroyakovskiy, Sergei A. Tjulandin, Ekaterina A. Trishkina, Liubov Iu. Vladimirova, Nikita M. Volkov, Yulia V. Kostalanova
Publikováno v:
Современная онкология, Vol 26, Iss 1, Pp 56-64 (2024)
Background. The use of cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in combination with endocrine therapy is a key initial treatment for advanced luminal HER2-negative (HR+/HER2-) breast cancer. The approval studies MONALEESA-2 and 7 demonstra
Externí odkaz:
https://doaj.org/article/38d513dc74f248e7bd74c0e83c57a19a
Autor:
Dmitry N. Maystrenko, Alexey G. Manikhas, Alla E. Chernobrovkina, Boris L. Tsivyan, Dmitry V. Gladyshev
Publikováno v:
Kazan medical journal. 103:269-277
Background. With the widespread prevalence of oncogynecological diseases, measures for their early detection and timely treatment, including the systematic implementation of all necessary medical and diagnostic measures within the framework of regula
Autor:
Cornelius C.M. Hageluken, Ernst Kubista, Michail Nechushkin, Mitch Dowsett, Alexey G. Manikhas, Juan V.M. Planellas Gomez, Kamil Pohlodek, Christian F. Singer, Jean-Michel Foidart, Rudolphe Serreyn, Victor F. Semiglazov
Publikováno v:
CLINICAL CANCER RESEARCH
Purpose: Tibolone is a selective tissue estrogenic activity regulator, approved for the treatment of vasomotor symptoms in postmenopausal women. We have done an exploratory, double-blind, randomized, placebo-controlled pilot trial to investigate the